Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapeutic Strategy for Acute Kidney Injury

Jia-Kun Li1, Cheng Yang2, Ying Su1

  • 1Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.

Insights

Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) show promise for treating acute kidney injury (AKI). MSC-EVs offer advantages over MSCs, including lower immunogenicity and easier storage, for potential AKI therapies.

Area of Science:

  • Nephrology
  • Regenerative Medicine
  • Biotechnology

Background:

  • Acute kidney injury (AKI) affects 10-15% of hospitalizations and 50% of ICU patients.
  • Severe AKI can progress to chronic kidney disease or end-stage renal disease.
  • Current AKI treatments are primarily supportive, necessitating more effective therapies.

Purpose of the Study:

  • To review the therapeutic mechanisms of Mesenchymal Stem Cells (MSCs) and MSC-derived Extracellular Vesicles (MSC-EVs) in AKI.
  • To explore recent advancements in enhancing MSC-EV efficacy for AKI treatment.
  • To analyze the potential and limitations of EVs for AKI therapy.

Main Methods:

  • Literature review of MSCs and MSC-EVs in AKI.
  • Analysis of therapeutic mechanisms and recent research findings.
  • Evaluation of the potential and limitations of EV-based therapies.

Main Results:

  • MSCs are promising for cellular therapy due to ease of harvesting and low immunogenicity.
  • Therapeutic effects of MSCs are mainly mediated by MSC-EVs.
  • MSC-EVs offer advantages over MSCs, including lower immunogenicity, easier storage, and no tumorigenesis.

Conclusions:

  • MSC-EVs represent a promising therapeutic strategy for AKI.
  • Further research and clinical trials are needed to optimize MSC-EV efficacy and application.
  • MSC-EVs have significant potential for the clinical treatment of AKI.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.3K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
432